Dual Use Research of Concern Policy - On Research Podcast

On Research - with CITI Program

Join us for a fascinating discussion about the recently updated Dual Use Research of Concern policy. There was so much to cover that I brought in two experts – one as my co-host and the other as our guest. If you don’t know much about Dual Use Research of Concern, this conversation will be a fantastic primer. We discuss what Dual Use means, the policy updates, how these updates could impact your research institution, and why all of this matters.

Also of note, we recorded this episode a couple of weeks ago, in the midst of the many executive orders impacting research. Anne and Melissa do share their thoughts on how you should move forward in this gray area we’ve all found ourselves in, but we always encourage folks to stay up to date as much as possible on the evolving landscape.

Additional Resources:

• DURC Policy released May 2024, effective May 2025 - https://bidenwhitehouse.archives.gov/wp-content/uploads/2024/05/USG-Policy-for-Oversight-of-DURC-and-PEPP.pdf
• Implementation Guidance for DURC policy - https://bidenwhitehouse.archives.gov/wp-content/uploads/2024/05/USG-DURC-PEPP-Implementation-Guidance.pdf
• Learn more about HRP Consulting: https://thehrpconsultinggroup.com/
• Learn more about CITI Program at about.citiprogram.org. 

Guest Bios:

Melissa James – Guest – Melissa is the BSL-3 Facility Manager for Yale University with 12+ years of high containment experience, including establishing and maintaining compliance with the Federal Select Agent Program. Her degrees in biology and Homeland Security and RBP credentials position her to share her vast knowledge and experience with others in the field.

Anne Hawkinsbadge – Guest Host – Anne is the Assistant Director of EHS. She is a Certified Safety Professional, Certified Healthcare Safety Professional, Certified Healthcare Emergency Professional, and a Chemist with the American Society of Clinical Pathology. Her work experience includes healthcare, auto manufacturing, pharmaceutical, academia, worker compensation insurance, and chemical manufacturing.